JPRN-UMIN000007918招募中未知
Safety and efficacy of lenalidomide, dexamethasone, and clarithromycin therapy in Japanese patients with multiple myeloma, a phase I/II study - lenalidomide, dexamethasone, and clarithromycin therapy in Japanese patients with multiple myeloma
ara Hospital Kinki University School Of Medicine0 个研究点目标入组 32 人开始时间: 2012年5月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cardiac infarction within 6 months Deep vein thrombosis or pulmonary embolism within 3 years Tuberculosis,herpes simplex keratitis, mycosis, or other active infections at baseline Uncontrollable diabetes mellitus, hypertension, peptic ulcer, or glaucoma Posterior capsule opacification Patients with mental illness Those who are considered as inappropriate to register by attending physicians Pregnant or breast feeding females Grade 2 or more peripheral neuropathy Any of following laboratory abnormalities Absolute neutrophil count < 1000 Platelet count< 75000 Creatinine clearance < 60 mL/ min Serum SGOT/AST or SGPT/ALT >3.0 x upper limit of normal Prior history of malignancies other than multiple myeloma unless the subject has been free of the disease for > 3 years Radiotherapy within 14 days Wound by recent organ surgery HIV-positive Known hypersensitivity to dexamethasone Known hypersensitivity to macrolides
研究者
相似试验
已完成
2 期
Efficacy and safety of lenalidomide and dexamethasone as consolidation therapy and lenalidomide as maintenance therapy after autologous stem cell transplantation for newly diagnosed multiple myelomaMultiple myelomaJPRN-UMIN000019918Gifu University Hospital20
进行中（未招募）
1 期
The combination of Lenalidomide and Dexamethasone with or without intensification by high-dose Melphalan in the treatment of multiple myelomaprimary treatment of multiple myeloma patients of age 60 till 75 yearsMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2008-004083-39-DEGMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbH348
招募中
不适用
ow dose of lenalidomide and dexamethasone therapy for eldery multiple myelomaRefractory or relapsed symptomatic multiple myelomaJPRN-UMIN000008918ishiwaki municipal hospital26
进行中（未招募）
不适用
Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002POEMS SYNDROMEMedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-003202-33-ITISTITUTO CLINICO HUMANITAS
进行中（未招募）
3 期
A clinical trial to study the effects of two drugs, Lenalidomide and Thalidomide given with low dose of Dexamethasone in patients with Multiple MyelomaCTRI/2015/06/005944Dr Reddys Laboratories Ltd